Niraj is currently the lead clinical pharmacist for the largest primary care provider in Leicester, Willows Health. As the pharmacist transformational lead and developmental lead, he oversees a team of 12 pharmacy professionals and is responsible for their professional development and ensuring clinical excellence through governance standards.
As a pharmacist primary care development adviser for the Royal College of General Practitioners, Niraj is also involved in the development and quality improvement of general practice and delivery of care. Having completed his PG Dip in clinical pharmacy, including independent prescribing, he is also currently the pharmacist training lead for the Willows academy working closely with medical and pharmacy schools to help train tomorrow’s healthcare professionals. Niraj has also completed the Centre for Pharmacy Postgraduate Education (CPPE) Primary Care Pharmacy Education Pathway (PCPEP) for primary care pharmacists.
His work within long term conditions and the projects he has been instrumental in have been acknowledged amongst some of the key lead drivers of change and improvement in local healthcare landscape and have rippled to influence change in the UK, providing him a platform to showcase the excellent progressive work which his entire team have all been instrumental in achieving. He is currently the primary care lead for the innovative iCKD/LUCID (Leicester, Leicestershire, and Rutland Chronic Kidney Disease Integrated Care Delivery) project and has worked closely with the UK Kidney Association (UKKA) to develop a peer-led consensus report on all future UKKA guidelines, along with helping mobilise the roll out of the KFRE calculations nationwide. Niraj has more recently founded the pioneering Willows Health Centre for CaReMe Excellence which aims to take population health management approach to lower local health inequalities and improve outcomes for high-risk patients in Leicester. Niraj’s team’s work in the proactive management for respiratory and cardiovascular-renal metabolic diseases has received merit and contributed to his team being named highly commended PCN of the Year and was used as examples of best practice, along with their role in research and new treatment discovery as a National Institute of Health Research (NIHR) accredited centre.
